Literature DB >> 25135598

Sleep and circadian rhythms in hospitalized patients with decompensated cirrhosis: effect of light therapy.

M De Rui1, B Middleton, A Sticca, A Gatta, P Amodio, D J Skene, S Montagnese.   

Abstract

Patients with liver cirrhosis often exhibit sleep-wake abnormalities, which are, at least to some extent, circadian in origin. A relatively novel non-pharmacological approach to circadian disruption is appropriately timed bright light therapy. The aims of this pilot study were to investigate sleep-wake characteristics of a well-characterized population of inpatients with cirrhosis, and to evaluate the efficacy of bright light therapy in the hospital setting. Twelve consecutive inpatients with cirrhosis underwent complete sleep-wake assessment, to include qualitative and semi-quantitative (actigraphic) indices of night-time sleep quality, daytime sleepiness, diurnal preference, habitual sleep timing, quality of life, mood and circadian rhythmicity [i.e. urine collections for measurement of the melatonin metabolite 6-sulphatoxymelatonin (aMT6s)]. Patients showed extremely impaired night sleep quality (Pittsburg Sleep Quality Index global score: 16.3 ± 2.1) and daytime sleepiness was common (Epworth Sleepiness Scale: 8.3 ± 3.2). Five patients were randomly assigned to a single room in which lighting was controlled in relation to timing, spectral composition and intensity (lights on at 06:30 and off at 22:30, blue-enriched, more intense light in the morning, red-enriched, less intense light in the afternoon/evening); the others stayed in identical rooms with standard lighting. Sleep diaries revealed poor sleep quality, prolonged sleep latency (67 ± 138 min) and a reduced sleep efficiency (69 ± 21%). These features were confirmed by actigraphy (sleep efficiency: 71 ± 13%; fragmentation index: 55 ± 15%). Quality of life was globally impaired, and mood moderately depressed (Beck Depression Inventory: 19.4 ± 7.9). Seven patients underwent serial urine collections: no circadian aMT6s rhythm was detected in any of them, neither at baseline, nor during the course of hospitalization in either room (n = 4). In conclusion, sleep and circadian rhythms in hospitalized, decompensated patients with cirrhosis are extremely compromised. Treatment with bright light therapy did not show obvious, beneficial effects, most likely in relation to the severity of disturbance at baseline.

Entities:  

Mesh:

Year:  2014        PMID: 25135598     DOI: 10.1007/s11064-014-1414-z

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  44 in total

1.  Subjective and objective sleepiness in the active individual.

Authors:  T Akerstedt; M Gillberg
Journal:  Int J Neurosci       Date:  1990-05       Impact factor: 2.292

2.  Changes in the 24-h plasma cortisol rhythm in patients with cirrhosis.

Authors:  Sara Montagnese; Benita Middleton; Ali R Mani; Debra J Skene; Marsha Y Morgan
Journal:  J Hepatol       Date:  2010-10-14       Impact factor: 25.083

3.  A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms.

Authors:  J A Horne; O Ostberg
Journal:  Int J Chronobiol       Date:  1976

4.  High prevalence of sleep disturbance in cirrhosis.

Authors:  J Córdoba; J Cabrera; L Lataif; P Penev; P Zee; A T Blei
Journal:  Hepatology       Date:  1998-02       Impact factor: 17.425

5.  Mathematical and statistical analysis of circadian rhythms.

Authors:  D S Minors; J M Waterhouse
Journal:  Psychoneuroendocrinology       Date:  1988       Impact factor: 4.905

6.  A two process model of sleep regulation.

Authors:  A A Borbély
Journal:  Hum Neurobiol       Date:  1982

Review 7.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

8.  Sleep during the Antarctic winter: preliminary observations on changing the spectral composition of artificial light.

Authors:  Gavin Francis; Lyndsey Bishop; Claire Luke; Benita Middleton; Peter Williams; Josephine Arendt
Journal:  J Sleep Res       Date:  2008-06-28       Impact factor: 3.981

9.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

10.  Night-shift work in Antarctica: sleep characteristics and bright light treatment.

Authors:  J K Ross; J Arendt; J Horne; W Haston
Journal:  Physiol Behav       Date:  1995-06
View more
  14 in total

1.  Sleepless in the hospital: A systematic review of non-pharmacological sleep interventions.

Authors:  Megan A Miller; Brenna N Renn; Frances Chu; Nicole Torrence
Journal:  Gen Hosp Psychiatry       Date:  2019-05-24       Impact factor: 3.238

2.  Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.

Authors:  Jatinderpal Singh; Barjesh Chander Sharma; Vinod Puri; Sanjeev Sachdeva; Siddharth Srivastava
Journal:  Metab Brain Dis       Date:  2017-01-09       Impact factor: 3.584

Review 3.  Adding Insult to Injury: Sleep Deficiency in Hospitalized Patients.

Authors:  Wissam Mansour; Melissa Knauert
Journal:  Clin Chest Med       Date:  2022-06       Impact factor: 4.967

4.  Quality and Quantity of Sleep and Factors Associated With Sleep Disturbance in Hospitalized Patients.

Authors:  Hilde M Wesselius; Eva S van den Ende; Jelmer Alsma; Jan C Ter Maaten; Stephanie C E Schuit; Patricia M Stassen; Oscar J de Vries; Karin H A H Kaasjager; Harm R Haak; Frederiek F van Doormaal; Jacobien J Hoogerwerf; Caroline B Terwee; Peter M van de Ven; Frank H Bosch; Eus J W van Someren; Prabath W B Nanayakkara
Journal:  JAMA Intern Med       Date:  2018-09-01       Impact factor: 21.873

5.  Use of Actigraphy for the Evaluation of Sleep Disorders and Circadian Rhythm Sleep-Wake Disorders: An American Academy of Sleep Medicine Systematic Review, Meta-Analysis, and GRADE Assessment.

Authors:  Michael T Smith; Christina S McCrae; Joseph Cheung; Jennifer L Martin; Christopher G Harrod; Jonathan L Heald; Kelly A Carden
Journal:  J Clin Sleep Med       Date:  2018-07-15       Impact factor: 4.062

6.  The influence of environmental factors on sleep quality in hospitalized medical patients.

Authors:  Milena Bano; Federica Chiaromanni; Michela Corrias; Matteo Turco; Michele De Rui; Piero Amodio; Carlo Merkel; Angelo Gatta; Gabriella Mazzotta; Rodolfo Costa; Sara Montagnese
Journal:  Front Neurol       Date:  2014-12-11       Impact factor: 4.003

Review 7.  Managing Sleep Disturbances in Cirrhosis.

Authors:  Xun Zhao; Philip Wong
Journal:  Scientifica (Cairo)       Date:  2016-05-03

8.  Skin temperature variability is an independent predictor of survival in patients with cirrhosis.

Authors:  Matteo Bottaro; Noor-Ul-Hoda Abid; Ilias El-Azizi; Joseph Hallett; Anita Koranteng; Chiara Formentin; Sara Montagnese; Ali R Mani
Journal:  Physiol Rep       Date:  2020-06

Review 9.  Assessment and Management of Sleep Disturbance in Cirrhosis.

Authors:  Chiara Formentin; Maria Garrido; Sara Montagnese
Journal:  Curr Hepatol Rep       Date:  2018-02-13

10.  Is melatonin associated with pro-inflammatory cytokine activity and liver fibrosis in non-alcoholic fatty liver disease (NAFLD) patients?

Authors:  Masoudreza Sohrabi; Ali Gholami; Bahareh Amirkalali; Mahsa Taherizadeh; Mahsa Kolahdoz; Fahimeh SafarnezhadTameshkel; Sheida Aghili; Marzieh Hajibaba; Farhad Zamani; Mohsen Nasiri Toosi; Hossein Keyvani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.